SCHEMBL11169014

SCHEMBL11169014

Cc1ccccc1-c1ccccc1NC1=NCCN1

nearest known ligand 0.77

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 3/20 0.77
ADRA2A P08913 2/20 0.77
ADRA2C P18825 2/20 0.77
ADRA2B P18089 1/20 0.77
ADRA1D P25100 1/20 0.77
ADRA1B P35368 1/20 0.77
HTR7 P34969 1/20 0.64
HTR1D P28221 1/20 0.60
NISCH Q9Y2I1 1/20 0.55
CFB P00751 2/20 0.50
KCNH2 Q12809 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8020019 0.87 ADRA2A (1.00) ADRA1AADRA2AADRA2CADRA2BADRA1D
SCHEMBL11165537 0.82 ADRA2A (0.60) ADRA1AADRA2AADRA2CADRA2BADRA1D
SCHEMBL11160978 0.82 ADRA2A (0.69) ADRA1AADRA2AADRA2CADRA2BADRA1D
SCHEMBL11159084 0.82 ADRA2A (0.59) ADRA1AADRA2AADRA2CADRA2BADRA1D
SCHEMBL11160707 0.82 ADRA2A (0.59) ADRA1AADRA2AADRA2CADRA2BADRA1D
SCHEMBL11161109 0.82 ADRA2A (0.60) ADRA1AADRA2AADRA2CADRA2BADRA1D
SCHEMBL1741885 0.81 ADRA2A (0.77) ADRA1AADRA2AADRA2CADRA2BADRA1D
SCHEMBL11161510 0.81 ADRA2A (0.76) ADRA1AADRA2AADRA2CADRA2BADRA1D
SCHEMBL11162465 0.81 ADRA2A (0.58) ADRA1AADRA2AADRA2CADRA2BADRA1D
SCHEMBL11160952 0.79 ADRA2A (0.68) ADRA1AADRA2AADRA2CADRA2BADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0017484-B1 2-IMIDAZOLINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THE PHARMACEUTICAL COMPOSITION OF THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-04-06 EP disclosed
EP-0017484-A1 2-Imidazoline derivatives, process for the preparation thereof and the pharmaceutical composition of the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-10-15 EP disclosed